Caution of retinal toxicity using chloroquine and hydroxychloroquine in the treatment of COVID-19

Caution of retinal toxicity using chloroquine and hydroxychloroquine in the treatment of COVID-19

“Chloroquine phosphate” was listed as a trial drug in diagnosis and treatment program of COVID-19(trial sixth edition), and the application of chloroquine and hydroxychloroquine treatment for COVID-19 in medical institutions also increased. Chloroquine and hydroxychloroquine have certain retinal tox...

Full description

Bibliographic Details
Main Authors:	Li-Yuan Wang, He Sun
Format:	Article
Language:	English
Published:	Press of International Journal of Ophthalmology (IJO PRESS) 2020-07-01
Series:	Guoji Yanke Zazhi
Subjects:	chloroquine hydroxychloroquine covid-19 retinal toxicity
Online Access:	http://ies.ijo.cn/cn_publish/2020/7/202007039.pdf

Similar Items

Chloroquine and hydroxychloroquine for COVID-19 treatment
by: Dwi Aris Agung Nugrahaningsih, et al.
Published: (2020-05-01)

Repurposing Drugs for COVID-19: Pharmacokinetics and Pharmacogenomics of Chloroquine and Hydroxychloroquine
by: Babayeva M, et al.
Published: (2020-10-01)

Hydroxychloroquine and chloroquine in prophylaxis and treatment of COVID-19: What is known?
by: Pathiyil Ravi Shankar, et al.
Published: (2021-01-01)

Chloroquine, hydroxychloroquine, and COVID-19: Systematic review and narrative synthesis of efficacy and safety
by: Michael Takla, et al.
Published: (2020-12-01)

Review on the global epidemiological situation and the efficacy of chloroquine and hydroxychloroquine for the treatment of COVID-19
by: S. Saqrane, et al.
Published: (2020-05-01)

Chloroquine and Hydroxychloroquine: Efficacy in the Treatment of the COVID-19
by: Tzu-Chuan Ho, et al.
Published: (2021-02-01)

Computational Studies of Hydroxychloroquine and Chloroquine Metabolites as Possible Candidates for Coronavirus (COVID-19) Treatment
by: Niteen A. Vaidya, et al.
Published: (2020-11-01)

Research Progress of Chloroquine and Hydroxychloroquine on the COVID-19 and Their Potential Risks in Clinic Use
by: Yan Chen, et al.
Published: (2020-07-01)

Prevention and treatment of COVID-19: Focus on interferons, chloroquine/hydroxychloroquine, azithromycin, and vaccine
by: Bianza Moise Bakadia, et al.
Published: (2021-01-01)

Early hydroxychloroquine but not chloroquine use reduces ICU admission in COVID-19 patients
by: A.J.J. Lammers, et al.
Published: (2020-12-01)

Off-Label Use of Chloroquine and Hydroxychloroquine for COVID-19 Treatment in Africa Against WHO Recommendation
by: Belayneh A
Published: (2020-09-01)

Hydroxychloroquine/chloroquine in patients with COVID-19 in Wuhan, China: a retrospective cohort study
by: Zhe Chen, et al.
Published: (2021-08-01)

The Rise and Fall of Chloroquine/Hydroxychloroquine as Compassionate Therapy of COVID-19
by: Elangovan Manivannan, et al.
Published: (2021-05-01)

Systematic review and meta-analysis of efficacy and safety of hydroxychloroquine and chloroquine in the treatment of COVID-19
by: Niti Mittal, et al.
Published: (2021-01-01)

Clinical Implications of Chloroquine and Hydroxychloroquine Ototoxicity for COVID-19 Treatment: A Mini-Review
by: Pattarawadee Prayuenyong, et al.
Published: (2020-05-01)

Comparative study between visual evoked potential and visual acuity, field of vision, and fundus examination as screening tool for early diagnosis of hydroxychloroquine and chloroquine retinal toxicity in rheumatic patients
by: Abeer H Ismaiel, et al.
Published: (2020-01-01)

Hydroxychloroquine as prophylaxis or treatment for COVID-19: What does the evidence say?
by: Praveen Balabaskaran Nina, et al.
Published: (2020-01-01)

Chloroquine and hydroxychloroquine in the context of COVID-19
by: Ashutosh M Shukla, et al.
Published: (2020-04-01)

Should chloroquine and hydroxychloroquine be used to treat COVID-19? A rapid review
by: Kome Gbinigie, et al.
Published: (2020-04-01)

Biological, molecular and pharmacological characteristics of chloroquine, hydroxychloroquine, convalescent plasma, and remdesivir for COVID-19 pandemic: A comparative analysis
by: Sultan Ayoub Meo, et al.
Published: (2020-10-01)

Oxidative Stress, Proton Fluxes, and Chloroquine/Hydroxychloroquine Treatment for COVID-19
by: Christina B. Klouda, et al.
Published: (2020-09-01)

Chloroquine and hydroxychloroquine – safety profile of potential COVID-19 drugs from the rheumatologist’s perspective
by: Dominik Majewski, et al.
Published: (2021-03-01)

Nanomedicine Reformulation of Chloroquine and Hydroxychloroquine
by: David M. Stevens, et al.
Published: (2021-12-01)

An umbrella review of systematic reviews with meta-analyses evaluating positive and negative outcomes of Hydroxychloroquine and chloroquine therapy
by: Stefano Celotto, et al.
Published: (2021-02-01)

Sensitivity and Specificity of Multifocal Electroretinography in Detecting Chloroquine and Hydroxychloroquine Retinal Toxicity
by: Ahmadi Pirshahid, Sina
Published: (2015)

Beyond Anti-viral Effects of Chloroquine/Hydroxychloroquine
by: Vincent Gies, et al.
Published: (2020-07-01)

When there is a pandemic there is no time to waste: should we have hydroxychloroquine in our armoury against COVID-19 infected patients?
by: Dimitrios P. Bogdanos, et al.
Published: (2019-01-01)

Chloroquine and COVID-19: Should We Care about Ototoxicity?
by: Eduardo Machado Rossi Monteiro, et al.
Published: (2020-07-01)

Systematic Review and Pharmacological Considerations for Chloroquine and Its Analogs in the Treatment for COVID-19
by: Hongwei Peng, et al.
Published: (2020-10-01)

Chloroquine and Hydroxychloroquine for the Prevention and Treatment of COVID-19: A Fiction, Hope or Hype? An Updated Review
by: Saghir SAM, et al.
Published: (2021-04-01)

QT interval and repolarization dispersion changes during the administration of hydroxychloroquine/chloroquine with/without azithromycin in early COVID 19 pandemic: A prospective observational study from two academic hospitals in Indonesia
by: Rizki A. Gumilang, et al.
Published: (2021-10-01)

Drug Interactions and Side Effects of Co-Administration of Chloroquine/Hydroxychloroquine and Azithromycin: on the Issue of Rational Pharmacotherapy of Patients with COVID-19 with Antimalarial Drugs
by: O. V. Gaisenok
Published: (2020-07-01)

QTc Prolongation Risk Evaluation in Female COVID-19 Patients Undergoing Chloroquine and Hydroxychloroquine With/Without Azithromycin Treatment
by: Sarah Grewal, et al.
Published: (2020-09-01)

Chloroquine: An Old to be Repurposed Drug For COVID-19 Infection (Risk and Benefit)
by: Oki Nugraha Putra, et al.
Published: (2020-07-01)

Mutagenic, Genotoxic and Immunomodulatory effects of Hydroxychloroquine and Chloroquine: a review to evaluate its potential to use as a prophylactic drug against COVID-19
by: Allan Giri, et al.
Published: (2020-09-01)

Chloroquine and Hydroxychloroquine Myopathy: Clinical Spectrum and Treatment Outcomes
by: Elie Naddaf, et al.
Published: (2021-02-01)

Hydroxychloroquine: A Familiar Agent to Combat the Pandemic of COVID-19
by: Vasilios M. Polymeropoulos
Published: (2020-04-01)

Chloroquine/hydroxychloroquine use and suicide risk: Hypotheses for confluent etiopathogenetic mechanisms?
by: Aguglia, A., et al.
Published: (2021)

Administration of chloroquine or hydroxychloroquine through feeding tubes: new challenges in times of coronavirus pandemic
by: Mariana Martins Gonzaga do Nascimento, et al.
Published: (2020-04-01)

Use of hydroxychloroquine and chloroquine in COVID-19: How good is the quality of randomized controlled trials?
by: Faizan Mazhar, et al.
Published: (2020-12-01)